Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Most humans are resistant to Mycobacterium tuberculosis (Mtb) and form granulomas that limit inflammatory
tissue damage. Nevertheless, tuberculosis (TB) remains a leading infectious cause of death globally because a
fraction of infected individuals develops massive necrotic granulomas and transmit Mtb via aerosols. This
outcome of Mtb infection is relatively uncommon among immunocompetent humans, and its mechanisms are
poorly characterized. We will study both host vulnerability (predisposition to necrotization of TB granulomas) and
Mtb virulence determinants (the necrosis-inducing factor) to determine how their interactions lead to necrosis in
susceptible but otherwise immunocompetent hosts.
We will address this major knowledge gap using a well-characterized mouse model developed in our laboratory
that recapitulates the formation of organized human-like necrotic pulmonary TB granulomas (mice with the
susceptibility allele of the sst1(super-susceptibility to tuberculosis, sst1) locus) Our recent studies reveal that
inadequate antioxidant defense (AOD) drives an aberrant response of the sst1 mutant macrophages to TNF and
induce hyperactivity of type I interferon pathway (IFN-I). This mouse model also provides a unique opportunity
to study the role of a recently discovered Tuberculosis Necrotizing Toxin (TNT).
The major premise of this application is that impaired stress resilience of macrophages due to inadequate
antioxidant defense (AOD) is exploited by Mtb to subvert local immunity within pulmonary TB granulomas of
immunocompetent hosts and induce necrosis. We will investigate: (i) Crosstalk of Myc and IFN-I pathways in the
deregulation of antioxidant response in activated macrophages. (ii) Host regulators of the anti-oxidant response
and necrosis in vivo. This aim will address our hypothesis about the hierarchy of the antioxidant defense and
IFN-I pathways in vivo and test whether boosting the antioxidant defense prevents the granuloma necrotization
and reduce the IFN-I hyperactivity. (iii) Role of the Mtb Tuberculosis Necrotizing Toxin (TNT) in driving necrosis
in TB granulomas of the susceptible but immunocompetent hosts.
The ultimate goal of our studies is to develop mechanistic interventions to target necrosis in TB granulomas in
order to overcome a major obstacle to the sterilization of TB lesions with antibiotics. This will improve the
outcomes of TB chemotherapy and prevent the evolution and spread of drug resistant TB.
Public Health Relevance Statement
PROJECT NARRATIVE
Only a minor fraction of immunocompetent humans develop tuberculosis with massive necrotic granulomas and
cavitation in their lungs, but the host mechanisms causing this vulnerability are poorly characterized. We will use
a well characterized mouse model that recapitulates the formation of organized necrotic pulmonary tuberculosis
(TB) granulomas to examine the interplay of host mechanisms of susceptibility with the necrosis-inducing factor
of virulent Mycobacterium tuberculosis (Mtb). Because necrosis of TB granulomas is a major obstacle to the
sterilization of TB lesions with antibiotics, this study will lead to host-directed therapies that will synergize with
antibiotics to shorten and improve TB chemotherapy.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AerosolsAntibioticsAntioxidantsAutomobile DrivingCause of DeathCellsCessation of lifeDataDissectionDrug resistanceDrug resistance in tuberculosisEvolutionFerritinGeneticGenetic TranscriptionGoalsGranulomaHumanHydrolysisHyperactivityImmuneImmune responseImmunityImmunocompetentImmunologicsImpairmentIn VitroInbred MouseIndividualInflammatoryInterferon Type IInterventionIronKnowledgeLaboratoriesLeadLesionLinkLipid PeroxidationLungMacrophageMediatingMinorMusMycobacterium tuberculosisNADPNecrosisNecrosis InductionOutcomePathogenesisPathway interactionsPatternPopulationPredispositionProductionPulmonary TuberculosisReporterResistanceRoleSterilizationSusceptibility GeneTNF geneTestingTherapeuticTissuesToxinTuberculosisVirulenceVirulentVisualizationgenomic locushuman modelimprovedimproved outcomein vivomouse geneticsmouse modelmutantnon-necrotizing granulomasoxidative damagepathogenpreventproteostasis lossresilienceresponsestress resiliencesuccesssynergismtransmission processtuberculosis chemotherapytuberculosis granuloma
No Sub Projects information available for 5R01HL126066-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL126066-08
Patents
No Patents information available for 5R01HL126066-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL126066-08
Clinical Studies
No Clinical Studies information available for 5R01HL126066-08
News and More
Related News Releases
No news release information available for 5R01HL126066-08
History
No Historical information available for 5R01HL126066-08
Similar Projects
No Similar Projects information available for 5R01HL126066-08